Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.47 |
| ▸ | CES1 | P23141 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.40 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.40 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1364589 | 0.83 | CES2 (0.47) | CES2CES1ALDH1A1ALOX15CLCN2 | |
| SCHEMBL2560228 | 0.83 | CES2 (0.50) | CES2CES1CLCN2MAPK14MAPK13 | |
| SCHEMBL29728646 | 0.81 | KEAP1 (0.53) | CES2CES1ALDH1A1CLCN2KEAP1 | |
| SCHEMBL30628278 | 0.81 | CES2 (0.48) | CES2CES1ALDH1A1KEAP1HDAC4 | |
| SCHEMBL1121927 | 0.81 | CES2 (0.48) | CES2CES1ALDH1A1KEAP1HDAC4 | |
| SCHEMBL543572 | 0.81 | KEAP1 (0.53) | CES2CES1ALDH1A1CLCN2KEAP1 | |
| SCHEMBL11476969 | 0.81 | CES2 (0.48) | CES2CES1CLCN2MAPK14MAPK13 | |
| SCHEMBL9834572 | 0.80 | CES2 (0.52) | CES2CES1ALDH1A1ALOX15KEAP1 | |
| SCHEMBL26019658 | 0.80 | CES2 (0.44) | CES2CES1ALDH1A1CLCN2MAPK14 | |
| SCHEMBL10971858 | 0.79 | CES2 (0.47) | CES2CES1CLCN2MAPK14MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899093-A | Synthesis process of 6-fluoro-2-methyl-1-indenone | 重庆恩联生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-111100059-A | Structural design and synthesis of novel carbazole oxime ester photoinitiator | 北京艾德旺科技发展有限公司 | 2020-05-05 | — | — | CN | claimed |
| WO-2025110008-A1 | CURABLE COMPOSITION, METHOD FOR PRODUCING PIXEL, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND PHOTOPOLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025110009-A1 | CURABLE COMPOSITION, METHOD FOR PRODUCING PIXEL, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND PHOTOPOLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2025-05-30 | — | — | WO | disclosed |
| CN-119899093-A | Synthesis process of 6-fluoro-2-methyl-1-indenone | 重庆恩联生物科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| US-20240228501-A1 | IMIDAZOLE-CONTAINING CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE | CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| WO-2024111393-A1 | CURABLE COMPOSITION, METHOD FOR PRODUCING CURED ARTICLE, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2024-05-30 | — | — | WO | disclosed |
| EP-4293023-A1 | IMIDAZOLE-CONTAINING CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE | Changchun Genescience Pharmaceutical Co., Ltd. (CN) | 2023-12-20 | — | — | EP | disclosed |
| CN-117177974-A | Imidazole-containing condensed ring derivative, preparation method and medical application thereof | 长春金赛药业有限责任公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-111132963-B | Compound, composition, cured product, and method for producing cured product | 株式会社艾迪科 | 2023-11-24 | — | — | CN | disclosed |
| CN-114349714-B | Dibenzodiazepine derivative and preparation method and application thereof | 华中师范大学 | 2023-09-29 | — | — | CN | disclosed |
| EP-1780209-B1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SUCH COMPOUND | ADEKA CORP (JP) | 2010-03-10 | — | — | EP | disclosed |
| US-20090004185-A1 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF BETA-CATENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | WYETH (US) | 2009-01-01 | — | — | US | disclosed |
| WO-2008086462-A2 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | WYETH (US) | 2008-07-17 | — | — | WO | disclosed |
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | ADEKA CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | ADEKA CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | ADEKA CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| EP-1780209-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SUCH COMPOUND | Adeka Corporation (JP) | 2007-05-02 | — | — | EP | disclosed |
| WO-1993014086-A1 | SUBSTITUTED 1-ISOQUINOLONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS | SYNTEX (U.S.A.) INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| US-4016274-A | TRANQUILIZERS AND ANTICONVULSANT AGENTS | RHONE-POULENC S.A. (FR) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004185-A1 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF BETA-CATENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | TCF4, CTNNB1, TCF7 | CES2 4605/4885CES1 2720/4885ALDH1A1 2808/4885 |
| US-20240228501-A1 | IMIDAZOLE-CONTAINING CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE | KISS1R, CYP3A43, SLC6A11 | CES2 2909/4885CES1 2141/4885ALDH1A1 1460/4885 |
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | CBR3, CBR1, SCLY | CES2 126/4885CES1 502/4885ALDH1A1 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.